In the February 2021 edition of the Market Update: Macroeconomic indicators remain robust, but vaccine supply delays in some regions and the emergence of new Covid-19 strains have dampened sentiment. The US congress is negotiating President Biden’s proposed US$1.9 trillion stimulus package, … [Read more...]

Having greater exposure to risk in the current environment where interest rates are more likely to rise than fall further, leaves portfolios vulnerable to losses if the interest rate regime suddenly shifts higher. In response, with the risk of both inflation and continued disinflation at the fore, … [Read more...]

In the January 2021 report Al Clark, Head of Investments, Ben McCaw, Senior Portfolio Manager, and John Woods, Portfolio Manager, explain MLC's assessment of the current market environment, pandemic scenarios that may play out, and how MLC multi-asset portfolios are positioned. This update includes … [Read more...]

In the January 2021 edition of the Market Update: Globally there were over 85 million confirmed Covid-19 cases at the start of January and over 20 million in the United States alone. Democrat wins in the Georgia runoff election will give the incoming Biden administration more flexibility … [Read more...]

In this update, Bob Cunneen, Porfolio Specialist, reviews events in markets during November. He discusses: Global share markets made a gain of around 11% in November There has been very encouraging economic data coming out of the US and China, suggesting that a global recovery has begun … [Read more...]

In the December 2020 edition of the Market Update: Joe Biden is the projected winner of the US presidential election, with the passing of the ‘safe harbour’ deadline making it hard for legal challenges to change the outcome. Globally there were over 60 million confirmed Covid-19 cases at the … [Read more...]

In the November 2020 edition of the Market Update: Joe Biden has convincingly won the US Presidential Election Markets were buoyed in November by the successful trial of the Pfizer/BioNtech vaccine, which is expected to be approved by the FDA later in the month. Rising COVID-19 cases in … [Read more...]

In this update, Bob Cunneen, Porfolio Specialist, reviews events in markets during October. He discusses: The American share market fell 2.7% and European share markets fell 5% in October – largely caused by the threat of the virus Joe Biden has won the US Presidential Election The … [Read more...]